MySkin Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
MySkin General Information
Description
Provider of skin microbiome contract analysis services intended to provide genome information of microorganisms. The company offers a range of services including skin kit, Metagenome analysis, and options analysis, enabling patients to receive an analysis and report on their microbiome by sending a skin sample.
Contact Information
Website
www.myskin.jp(Operating Subsidiary)
Corporate Office
- HiRAKU GATE 603, Todaimae
- 2-3-10 Mukogaoka, Bunkyo-ku
- Tokyo, 113-0033
- Japan
Corporate Office
- HiRAKU GATE 603, Todaimae
- 2-3-10 Mukogaoka, Bunkyo-ku
- Tokyo, 113-0033
- Japan
MySkin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Nov-2026 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Sep-2019 | Completed | Generating Revenue | |||
| 1. Corporate | 02-Aug-2016 | Completed | Generating Revenue |
MySkin Patents
MySkin Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026220914-A1 | Tape for collecting genomic dna and skin-resident microorganism, method for analyzing genomic dna of animal and skin-resident microorganism on surface of skin of animal, method for analyzing methylation of genomic dna, and method for predicting biological age | Pending | 17-Apr-2025 | ||
| JP-7037160-B1 | A prophylactic or therapeutic agent for at least one cancer selected from the group consisting of pancreatic cancer, lung cancer, colon cancer, bile duct cancer and liver cancer, and the prophylactic or therapeutic agent for the cancer in combination with the agent. a method for screening a therapeutic agent, a combination drug containing the agent, and a preventive or therapeutic agent for cancer. | Active | 01-May-2020 | ||
| JP-2022082537-A | A prophylactic or therapeutic agent for at least one cancer selected from the group consisting of pancreatic cancer, lung cancer, colorectal cancer, bile duct cancer and liver cancer, and the prophylactic or therapeutic agent for the cancer in combination with the agent. a method for screening a therapeutic agent, a combination drug containing the agent, and a preventive or therapeutic agent for cancer. | Pending | 01-May-2020 | ||
| EP-4137156-A1 | Prophylactic or therapeutic agent for at least one type of cancer selected from group consisting of pancreatic cancer, lung cancer, colorectal cancer, biliary tract cancer and liver cancer, prophylactic or therapeutic agent for said cancer which is used in combination drug in combination with said agent, combination drug comprising said agents, and method for screening for prophylactic or therapeutic agent for cancer | Pending | 01-May-2020 | ||
| EP-4137156-A4 | Prophylactic or therapeutic agent for at least one type of cancer selected from group consisting of pancreatic cancer, lung cancer, colorectal cancer, biliary tract cancer and liver cancer, prophylactic or therapeutic agent for said cancer which is used in combination drug in combination with said agent, combination drug comprising said agents, and method for screening for prophylactic or therapeutic agent for cancer | Pending | 01-May-2020 | C12N15/113 |
MySkin Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nippon Shokubai | Corporation | Minority | ||
| Seibu Shinkin Capital | Corporate Venture Capital | Minority |
MySkin FAQs
-
When was MySkin founded?
MySkin was founded in 2014.
-
Where is MySkin headquartered?
MySkin is headquartered in Tokyo, Japan.
-
What industry is MySkin in?
MySkin’s primary industry is Biotechnology.
-
Is MySkin a private or public company?
MySkin is a Private company.
-
What is MySkin’s current revenue?
The current revenue for MySkin is .
-
Who are MySkin’s investors?
Nippon Shokubai and Seibu Shinkin Capital have invested in MySkin.
-
When was MySkin acquired?
MySkin was acquired on 01-Nov-2026.
-
Who acquired MySkin?
MySkin was acquired by Varinos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process